Peru
Peru has signed an agreement with Chinese pharmaceutical firm Sinopharm to acquire its vaccine against COVID-19, with the first 1 million doses to arrive this month, Peruvian President Francisco Sagasti announced on Jan 6.
In a nationwide address, Sagasti said Peru's cooperation in Sinopharm phase 3 trials placed the country "in a better position to access vaccines" and to "verify their effectiveness in the national population."